Sleep and Stroke by Srivastav, M V Padma
Ann Natl Acad Med Sci (India), 49(3&4): 169-176, 2013
Sleep and Stroke
Circadian variations in conjunction with sleep-related heart rhythm changes and sleep 
disordered breathing (SDB) are contributing risk factors for stroke. Strong scientiﬁc 
evidence now exists indicating that SDB contributes to systemic hypertension, a 
prominent risk factor for stroke, and compelling circumstantial evidence is present 
suggesting that SDB raises the risk for development of stroke through other circulatory 
mechanisms as well. Preliminary evidence indicates that post-stroke patients have a 
higher prevalence of SDB, which is likely to compromise their rehabilitation outcomes. 
Since SDB is modiﬁable with the application of CPAP and other treatment modalities, 
there is practical value in investigating patients at risk of stroke or post stroke for 
presence of SDB. Successful application of CPAP or BiPAP therapy may improve the 
outcome in both instances. 
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ABSTRACT
Most strokes occur as a result of 
the concerted action of risk factors, 
prominent among which are age, 
hypertension, ischemic heart disease, 
diabetes and smoking. The awareness of 
new risk factors provides the opportunity 
to activate more preventive measures. 
Such is the case with obstructive sleep 
apnea (OSA). The role of sleep apnea 
disorder in circulatory alteration and 
vascular injury is a recently developed 
concept. 
Circadian Variations Inﬂuential in 
Circulatory and Vascular Phenomena :
Many physiological systems 
directly involved in functions of the 
circulatory system are affected by the 
circadian rhythm and interact in a chain of 
events with far-reaching ramiﬁcations. 
Such are the endocrine secretions, 
thermoregulation, renal functions, 
respiratory control, heart rhythm, 
hematologic parameters, immune system 
and drug metabolism. 
Plasma catecholamine levels rise 
from 6 AM to noon in parallel with an 
increase in heart rate and blood pressure. 
Fibrinolytic activity is reduced in the 
mornings while platelet aggregability is 
elevated. These phenomenons have been 
linked to increased vascular morbidity 
during morning hours. 
A number of studies have shown 
that stroke onset is more common between 
6 AM and non during the 24 hour cycle; 
the most critical period occurs 1 hour after 
awakening. Several factors have been 
proposed as possibly inﬂuential in this 
cyclical occurrence, including cortisol 
rhythm, hemodynamic variability, 
increased platelet aggregability, changes 
in blood viscosity and decreased 
ﬁbrinolytic activity (1).
Snoring :
Pathologic  snor ing  can  be 
described as the habitual harsh and loud 
vibratory sound produced by respiratory 
effort in the sleeping individual. Most 
individuals past middle age are snorers, 
but of importance to the clinician should 
be habitual, unabating, intensely loud 
snoring that is disturbing to others.  
Habitual snoring has been associated with 
arterial hypertension, ischemic heart 
disease and stroke. Sleep Disordered 
Breathing (SDB) can have serious 
cardiovascular and cerebrovascular 
consequences.
SDB and Stroke :
Abundant circumstantial evidence 
points to a causal association between 
SDB and stroke. Vascular risk factors, 
such as systemic hypertension, provide a 
slowly evolving indirect link to stroke in 
untreated SDB patients, while heart 
disease in any of its forms, as is widely 
appreciated, is a more direct pathway, if 
not a trigger, for stroke.
Sleep disordered breathing is a 
rubric under which OSA, snoring, upper 
airway resistance syndrome and central 
hypoventilation/apnea are included. OSA 
is the most common form of SDB and is 
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characterized by intermittent and 
repetitive episodes of partial or complete 
obstruct ion of  the upper  a irway, 
accompanied by elevated ai rway 
resis tance leading to apneas and 
hypopnoeas during sleep, both of which 
cause intermittent hypoxemia (2).
Epidemiology of OSA :
Sleep apnea is a common disorder, 
affecting up to 20% of the general 
population according to some reports. 
With two of the greatest risk factors for 
OSA being  age  and obes i ty,  the 
prevalence should increase with time as 
the population ages and waistlines bulge. 
Sleep apnea severity is measured by the 
apnea-hypopnea index (AHI). The AHI is 
a measure of the number of apneas, 
complete cessation of airﬂow and the 
number of hypopneas, reduction in 
airﬂow with desaturation or arousal, per 
hour of sleep. An AHI > 5 events/hour 
with symptoms of daytime somnolence, 
snoring or waking with gasping or 
choking or an AHI > 15 events/hour 
regardless of symptoms is considered 
diagnostic of OSA. The prevalence of 
sleep apnea is high in stroke patients – 
estimated to be between 50% and 70%. 
The most common type of sleep-
disordered breathing found after stroke or 
transient ischemic attacks (TIA) is OSA. 
It may predate the stroke, worsen during 
the acute stage and persist after the acute 
phase (2,3,4,5).
OSA and Stroke: Shared risk factors vs 
independent association :
The relationship between OSA 
and stroke is a complex one with shared 
risk factors as well as a likely independent 
association. Several studies have 
established OSA as a strong risk factor for 
hypertension, one of the leading risk 
factors for stroke. Studies have linked 
OSA to other major stroke risk factors, 
including insulin resistance, coronary 
artery disease,  heart  fai lure,  and 
arrhythmias. Individuals with OSA have a 
fourfold increased risk of atrial ﬁbrillation 
and a two to three fold higher risk of other 
complex arrhythmias ,  even af ter 
adjustment for potential confounders. 
Sleep apnea has also been suggested as an 
independent risk factor for stroke. 
Postulated mechanisms of OSA as an 
independent risk factor for stroke include 
tachyarrhythmias related to sympathetic 
a c t i v a t i o n ;  i m p a i r e d  c e r e b r a l 
hemodynamics as a consequence of blood 
p r e s s u r e  ﬂ u c t u a t i o n s ;  e n h a n c e d 
inﬂammation and oxidative stress 
associated with hypoxemia, including 
evidence for OSA activating nuclear 
factor kappa-B-mediated inﬂammatory 
p a t h w a y s  l e a d i n g  t o  s y s t e m i c 
i n ﬂ a m m a t i o n ;  p r o m o t i o n  o f 
atherosclerosis and thrombosis; abnormal 
coagulation markers, including plasma 
ﬁbrinogen levels and platelet reactivity 
and increased right-to-left shunting 
th rough  a  pa ten t  fo ramen  ova le 
(2,3,4,5,6,7,8).
Various studies also support 
casual association between hypertension 
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a n d  O S A .  T h e  a u t o n o m i c  a n d 
hemodynamic responses of OSA lead to 
acute surges in heart rate and blood 
pressure. Sleep heart health study 
demonstrated that sustained diurnal 
hypertension is a consequence of chronic 
OSA. The relative risk of hypertension in 
severe OSA (AHI> 30) compared with the 
mildest category (AHI < 1.5) in this study 
was 1.37 (95%, CI: 1.03-1.83), and the 
odds for hypertension increased with AHI 
in a dose-response manner. Another 
compelling evidence for OSA leading to 
hypertension is available from Wisconsin 
sleep cohort study, in which even after 
adjusting for baseline hypertension, age, 
gender, BMI, weekly cigarette and 
alcohol consumption,  the r isk of 
developing hypertension in people with 
an AHI of > 15 remained higher compared 
with those without OSA. Treatment of 
OSA with CPAP (Continue Positive 
Airway Pressure), compared to sham 
CPAP, reduced the hypertension, which 
further supports an association between 
OSA and hypertension. OSA may raise the 
systemic blood pressure signiﬁcantly and 
thus can be one of the most important 
mechanism by which OSA leads to 
cerebrovascular morbidity (2,3,4,5,6,7,8).
M e c h a n i s m  o f  i n t e r a c t i o n 
between OSA and normal blood pressure 
leading to hypertension has been studied 
and it is observed that patients with OSA 
have considerably higher sympathetic 
activity compared with controls, even 
during wakefulness. A modiﬁcation 
caused in renal physiology in the form of 
an  augmen ta t i on  o f  t he  r enn in -
angiotensin system in chronic OSA-
induced hypoxia has also been forwarded 
as an explanation for the genesis of 
hypertension in OSA. OSA is also been 
implicated in contributing to medically 
refractory hypertension.
The cardiac response to apnea 
consists of reduction of stroke volume, 
decreased heart rate and reduced cardiac 
ou tpu t .  These  changes  occu r  i n 
c o n v e r g e n c e  w i t h  p r o g r e s s i v e 
oxyhemoglobin desaturation and in 
p ro longed  apneas ,  w i th  g radua l 
hypercapnia. In patients with advanced 
SDB, cardiac arrhythmias, which are 
more abundant in older patients, appear 
when the oxyhemoglobin saturation falls 
below 65%. REM sleep is a most 
vulnerable time of the night for subjects 
with cardiovascular and cerebrovascular 
risk factors since cerebral blood ﬂow 
normally increases and cardiac rhythm 
variability is at a maximum in this stage. 
In SDB, REM sleep related atonia of 
dilator oropharyngeal muscles and loss of 
respira tory dr ive  dependency on 
chemoreceptor reﬂex activity result in 
more prolonged episodes of obstructive 
apnea. In consequence, the accompanying 
hypoxemia is more profound and the 
cardiac rhythm changes are more 
prominent, creating a dissociation 
between an increasing demand and a 
progressively faltering supply of blood 
ﬂow to the brain. (2-11)
TIA and silent infarctions may 
also occur at night while individuals are 
asleep, but proof is still missing. The most 
compelling circumstantial evidence that 
SDB affects cerebral hemodynamic 
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mechanisms comes  f rom s tudies 
investigating cerebral blood ﬂow 
velocities with ultrasound techniques in 
the middle cerebral artery (MCA) territory 
in patients with SDB. During the apnea 
event, signiﬁcant reduction in MCA blood 
ﬂow velocity occurs that correlates with 
the duration of the apnea that correlates 
with the duration of the apnea rather than 
with the depth of oxyhemoglobin 
desa tu ra t ion .  These  in t r ac ran ia l 
hemodynamic  changes  occurr ing 
repeatedly night after night in patients 
with marginal circulatory reserve may 
contribute to a raise in the risk of stroke. 
(2-11)
Acute Stroke and Sleep :
Inversion of the sleep-wake 
rhythm is commonly observed in the days 
that follow a large hemispheric stroke and 
is manifested by agitation during the night 
and lethargy during the day. The early 
presence of REM sleep and normal sleep 
cycles is a good prognostic sign. Location 
and extent of the stroke determine the type 
of sleep-related alteration. Neuronal 
centers controlling respiratory drive, 
pharyngeal motility, and some sleep 
functions are located in anatomic 
proximity in the tegmentum of the 
pontomedullary junction. Vascular injury 
to the respiratory centers in the lateral 
medullary syndrome may precipitate 
SDB. Other patterns of respiratory 
dysfunction noted with infratentorial 
lesions include apneusis or apnea during 
sustained inspiration, nonobstructive, 
obstructive and mixed apneas and failure 
of automatic breathing (so called Ondine's 
Curse). Sleep apnea events of the 
obstructive or non obstructive varieties 
with oxyhemoglobin desaturations may 
require administration of oxygen through 
a nasal cannula (12-16).
Patients with mesencephalic or 
paramedian thalamic lesions may exhibit 
excessive daytime somnolence as a result 
of loss of alerting mechanisms due to 
damage to reticular activating pathways 
and nuclei rather than development of 
OSA as such. Patients with hemispheric 
infarction demonstrate reduction of REM 
sleep during the acute stage proportional 
to the severity of neurologic deﬁcit. In 
bilateral hemispheric lesions, Cheyne-
Stokes respiration may be observed. 
The reported frequency of OSA in 
stroke patients varies between 30% and 
80%. In recent meta- analysis of ischemic 
or hemorrhagic stroke and TIA patients, 
the frequency of SDB with AHI of >5 was 
72 %, and with an AHI of >20 was 38%, it 
was reconﬁrmed by a previously reported 
higher prevalence of SDB (AHI>10) in 
men compared with women (65% vs. 
48%; p-0.001), and also a higher 
percentage of SDB (AHI>10) in patients 
with recurrent stroke than initial stroke 
(74% vs. 57%; p-0.013). Patients with 
cardio embolic strokes had a lower 
percentage of SDB compared with 
patients with strokes due to unknown 
etiologies (15,16).
OSA as a predictor of poor outcome 
after stroke :
If sleep apnea increases the risk of 
stroke, either directly or indirectly, 
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untreated patients with co-morbid OSA 
may have worse functional outcomes and 
higher mortality after acute stroke. 
Several observational studies suggest that 
OSA is a predictor of poor functional 
outcome after stroke, increasing the 
likelihood of dependency, and poststroke 
mortality. Potential mechanisms of OSA 
contributing to poor neurologic recovery 
include direct effects of reduced cerebral 
blood ﬂow and modulation of blood 
pressure and oxygen saturation associated 
with apneic episodes, resulting in further 
neurologic injury due to a compromise in 
perfusion to the ischemic penumbra. In 
the subacute setting of the recovering 
stroke patient, untreated OSA can also 
cause impaired cognitive function, 
decreased concentration and excessive 
d a y t i m e  s l e e p i n e s s ,  p r o l o n g i n g 
hospitalizations and compromising 
rehabilitation participation. (17,18,19)
Diagnosis of OSA after Stroke :
Randomized trials of CPAP after 
stroke suggest identifying OSA may be 
best accomplished with portable devices. 
The Sleep Apnea Treatment After Stroke 
(SATS) trial proposed screening with full 
polysomnography (PSG), but switched to 
portable monitoring early in the study sue 
to intolerance and logistical challenges of 
coordinating an in-laboratory PSG during 
the acute stroke period. 
Treatment of OSA after Stroke :
Treatment with CPAP has the 
unique potential to improve the recovery 
from stroke and to reduce the risk of 
recurrent stroke both indirectly through 
better control of multiple modiﬁable risk 
factors and directly through a variety of 
proposed mechanisms. It is an effective 
treatment for OSA, reducing OSA-
associated hypertension, atrial ﬁbrillation, 
cardiovascular morbidity and mortality, 
exclusive of stroke, and reducing daytime 
somnolence. CPAP provides a constant, 
positive pressure to the airway throughout 
the respiratory cycle, serving to open the 
upper airways to prevent narrowing or 
collapse. The impact of early treatment of 
OSA with CPAP on neurologic recovery 
after stroke is just beginning to be studied. 
Preliminary randomized trials of CPAP 
therapy after ischemic stroke have shown 
an improvement in stroke impairment 
scales, depressive symptoms, motor 
recovery, sleepiness, and the time until the 
appearance of cardiovascular events. 
Other randomized trials have shown no 
difference. Although results across the 
studies appear inconsistent, a few 
conclusions may guide neurologists to 
initiate CPAP in a stroke patient with 
OSA. The studies that have shown 
increased  CPAP adherence  have 
demonstrated greater improvements in 
stroke symptom recovery, while those 
limited by poor recruitment or adherence 
have been underpowered to show any 
signiﬁcant CPAP beneﬁt (17,18,19).
Treatment with CPAP may also 
reduce the risk of recurrent stroke in 
p a t i e n t s  w i t h  O S A d i r e c t l y.  A n 
observational study suggested that 
treating stroke patients with CPAP 
prevented recurrent stroke. Stroke 
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